Matches in Nanopublications for { ?s ?p "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1238600.RAU8e5WD5DJaRUl_6TPgf4aOMcyqN236Qfh2S4buVjMLw130_assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238600.RAU8e5WD5DJaRUl_6TPgf4aOMcyqN236Qfh2S4buVjMLw130_provenance.
- NP1238602.RAo1XsbyKea3GDYqs8i42TtawnXnxm9wVewAyLbDOtFAA130_assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238602.RAo1XsbyKea3GDYqs8i42TtawnXnxm9wVewAyLbDOtFAA130_provenance.
- NP1238601.RAG5SRUSjfq_18FBWcMTTxhLqOEa-4yABfn9G6yaTN6n4130_assertion description "[We tested several compounds in order to identify novel small molecules that prevent premature degradation of the mutant lysosomal enzymes ?-galactosidase A (for Fabry disease (FD)) and acid ?-glucosidase (GAA) (for Pompe disease (PD)).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238601.RAG5SRUSjfq_18FBWcMTTxhLqOEa-4yABfn9G6yaTN6n4130_provenance.